SNCA and Parkinson disease: For example, alpha-synuclein (α-syn) fibrils isolated from patients with Parkinson’s disease (PD), multiple system atrophy (MSA) or Lewy body dementia (LBD) exhibit distinct structures16–18, and injection of aggregates isolated from these patients results in distinct phenotypes and pathology patterns in mice19.